Thu, May 4, 2023

Brian Abrahams Reiterated (BCRX) at Hold and Held Target at $9 on, May 4th, 2023

Brian Abrahams of RBC Capital, Reiterated "BioCryst Pharmaceuticals, Inc." (BCRX) at Hold and Held Target at $9 on, May 4th, 2023.

Brian has made no other calls on BCRX in the last 4 months.



There are 3 other peers that have a rating on BCRX. Out of the 3 peers that are also analyzing BCRX, 0 agree with Brian's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Brian


  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $10 on, Thursday, April 20th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $30 on, Wednesday, February 22nd, 2023
  • Jonathan Wolleben of "JMP Securities" Reiterated at Buy and Held Target at $16 on, Wednesday, February 22nd, 2023